Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis J Stone

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|February 23, 2008
Unexceptional seizure potential of tramadol or its enantiomers or metabolites in miceRobert B Raffa, Dennis J Stone
Pain|May 29, 2007
Tramadol and several anticonvulsants synergize in attenuating nerve injury-induced allodyniaEllen E Codd, Rebecca P Martinez, Lory Molino, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2003
Design and synthesis of novel pyrrolidine-containing bradykinin antagonistsJung Lee, Charles Reynolds, Michele C Jetter, et al.
Neuron|May 8, 2007
Attenuated cold sensitivity in TRPM8 null miceRaymond W Colburn, Mary Lou Lubin, Dennis J Stone, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Synthesis and structure--activity relationships of aroylpyrrole alkylamide bradykinin (B2) antagonistsMark A Youngman, John R Carson, Jung S Lee, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Parallel methods for the preparation and SAR exploration of N-ethyl-4-[(8-alkyl-8-aza-bicyclo[3.2.1]oct-3-ylidene)-aryl-methyl]-benzamides, powerful mu and delta opioid agonistsSteven J Coats, Mark J Schulz, John R Carson, et al.
Pharmacology, Biochemistry, and Behavior|May 5, 2010
Ex vivo delta opioid receptor autoradiography: CNS receptor occupancy of two novel compounds over their antihyperalgesic dose rangeEllen E Codd, Jianya Ma, Sui-Po Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|March 17, 2012
The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonistsJay M Matthews, Ning Qin, Raymond W Colburn, et al.
Journal of Medicinal Chemistry|October 1, 2004
Rationale, design, and synthesis of novel phenyl imidazoles as opioid receptor agonists for gastrointestinal disordersHenry J Breslin, Tamara A Miskowski, Bryan M Rafferty, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2009
JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependenceEllen E Codd, John R Carson, Raymond W Colburn, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Journal of Pharmacology and Experimental Therapeutics|February 23, 2008
Unexceptional seizure potential of tramadol or its enantiomers or metabolites in miceRobert B Raffa, Dennis J Stone
Pain|May 29, 2007
Tramadol and several anticonvulsants synergize in attenuating nerve injury-induced allodyniaEllen E Codd, Rebecca P Martinez, Lory Molino, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2003
Design and synthesis of novel pyrrolidine-containing bradykinin antagonistsJung Lee, Charles Reynolds, Michele C Jetter, et al.
Neuron|May 8, 2007
Attenuated cold sensitivity in TRPM8 null miceRaymond W Colburn, Mary Lou Lubin, Dennis J Stone, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Synthesis and structure--activity relationships of aroylpyrrole alkylamide bradykinin (B2) antagonistsMark A Youngman, John R Carson, Jung S Lee, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Parallel methods for the preparation and SAR exploration of N-ethyl-4-[(8-alkyl-8-aza-bicyclo[3.2.1]oct-3-ylidene)-aryl-methyl]-benzamides, powerful mu and delta opioid agonistsSteven J Coats, Mark J Schulz, John R Carson, et al.
Pharmacology, Biochemistry, and Behavior|May 5, 2010
Ex vivo delta opioid receptor autoradiography: CNS receptor occupancy of two novel compounds over their antihyperalgesic dose rangeEllen E Codd, Jianya Ma, Sui-Po Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|March 17, 2012
The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonistsJay M Matthews, Ning Qin, Raymond W Colburn, et al.
Journal of Medicinal Chemistry|October 1, 2004
Rationale, design, and synthesis of novel phenyl imidazoles as opioid receptor agonists for gastrointestinal disordersHenry J Breslin, Tamara A Miskowski, Bryan M Rafferty, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2009
JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependenceEllen E Codd, John R Carson, Raymond W Colburn, et al.
Pageof 2